Try our Advanced Search for more refined results
Delaware
-
March 31, 2026
State Privacy Enforcers Broadening Work As Resources Grow
Privacy regulators from California, Connecticut and two other states said Tuesday that their behind-the-scenes enforcement work will soon yield public actions that focus not only on established topics such as consumer opt-outs and transparency, but also fresh issues like harms stemming from artificial intelligence and ensuring fines are more than just "a cost of doing business."
-
March 31, 2026
3rd Circ. Says Immigrant's Abuse Claims Need Further Review
The Third Circuit said Tuesday that further review was needed in the case of a Dominican national facing deportation to hash out whether his removal could be canceled based on federal law protecting immigrants from abuse from lawful permanent residents or citizens.
-
March 31, 2026
Del. Chancery Tosses B. Riley Investor Loss Suit
The Delaware Chancery Court dismissed a stockholder derivative lawsuit accusing B. Riley Financial Inc. insiders and directors of breaching their fiduciary duties over hundreds of millions of dollars in losses tied to the failed Franchise Group investment, ruling that the claims amounted to an impermissible hindsight critique of a risky business decision.
-
March 31, 2026
Del. Judge Won't Nix $60M Casablanca Hotel Award Case
A Delaware federal court rejected an investor's bid to escape litigation aimed at enforcing a $60 million arbitral award favoring the current owner of the Royal Mansour Hotel in Casablanca, pointing to a Third Circuit decision that reversed an earlier ruling by the lower court.
-
March 31, 2026
Moderna, Pfizer Want Bayer's COVID-Shot Patent Suits Tossed
Pharmaceutical giants Moderna and Pfizer-BioNTech have asked a Delaware federal judge to dismiss lawsuits seeking to recover royalties from sales of their respective COVID-19 vaccines, which plaintiff Bayer claims were made possible via infringement of its patent.
-
March 31, 2026
USPTO Tells Fed. Circ. Patent Panel Is Constitutional
The U.S. Patent and Trademark Office is urging the Federal Circuit to reject a British bookmaker's challenge to a review panel's revival of DraftKings' inter partes review of one of its patents, saying any constitutional challenges have to fail.
-
March 31, 2026
NJ Justices Reluctant To Stick Zurich With $2M UIM Bill
The New Jersey Supreme Court on Tuesday appeared skeptical that a TJX Cos. employee can recover up to the full $2 million limit in his employer's auto policy with Zurich American Insurance Co., rather than its $15,000 limit for underinsured motorists.
-
March 31, 2026
ITC Latest To Probe InterDigital Claims Against TCL, Hisense
The U.S. International Trade Commission is the latest venue to take up InterDigital's globe-spanning dispute against Chinese TV manufacturers Hisense Co. Ltd. and TCL Technology Group Corp., claiming the companies are importing TVs from the U.S. that infringe InterDigital's video coding patents.
-
March 31, 2026
Judge Further Delays Trump Admin's College Data Demand
A Massachusetts federal judge on Tuesday again pushed off a deadline for public colleges in 17 states to provide seven years of detailed admissions data to the U.S. Department of Education, as two organizations representing private schools seek to join a legal challenge to the new survey.
-
March 31, 2026
Mountain Sports Wins Ch. 11 Liquidation Plan OK
Sports retailer Mountain Sports LLC received confirmation Tuesday from a Delaware bankruptcy judge of its Chapter 11 liquidation plan after unsecured creditors backed the plan.
-
March 31, 2026
Cancer Vaccine Developer Files Ch. 7 After Trials Fall Short
A Denmark-based biotechnology firm filed for Chapter 7 liquidation Tuesday in Delaware with more than $10 million in debt after its prospective cancer vaccine failed to measure up under testing and win regulatory approval last year.
-
March 31, 2026
Teamsters Fund Sues To Block Clearway Reclassification
A Teamsters pension fund has filed a class action in the Delaware Chancery Court seeking to block a planned share reclassification by Clearway Energy Inc., alleging the deal would entrench the company's controlling stockholder while stripping public investors of voting power.
-
March 30, 2026
Don't Set Special IP Rules For 'Skinny Labels,' Justices Told
Drugmakers, industry groups, hospitals and scholars have urged the U.S. Supreme Court to uphold a decision letting a patent suit proceed over a generic drug using a so-called skinny label, saying the generics company is seeking unwarranted special protections that would upend patent law.
-
March 30, 2026
Ligado Settlement Payment Owed To Inmarsat Sent To Escrow
A Delaware bankruptcy judge Monday diverted a $100 million settlement payment that bankrupt telecom company Ligado Networks owed to satellite operator Inmarsat into escrow after Ligado alleged Inmarsat breached the deal.
-
March 30, 2026
Justices Told Fed. Circ. Wrongly Axed Car ID Patent Claims
A vehicle identification system patent owner wants the U.S. Supreme Court to review the Federal Circuit's reversal of the Patent Trial and Appeal Board's decision allowing the company to amend claims in two patents challenged by rideshare giant Lyft.
-
March 30, 2026
Patent Monetization Co. Looks To Sink $32M Arbitration Award
A patent monetization firm has sued a litigation funder and law firm Susman Godfrey LLP in Texas federal court, seeking to vacate an arbitration award that it says was riddled with errors.
-
March 30, 2026
Catching Up With Delaware's Chancery Court
The Delaware Chancery Court's docket this past week featured disputes involving globally recognized companies, high-dollar contract fights, revived claims from the state's high court and the resolution of a closely watched de-SPAC case.
-
March 30, 2026
Tilray Accused Of Dodging $11M In Bob Marley Royalties
Multistate cannabis giant Tilray owes more than $11 million in royalty payments for using Bob Marley's brand in connection with marijuana products, according to a new lawsuit filed in Delaware Chancery Court.
-
March 30, 2026
Del. Judge Upholds $34M Verdict In Glaucoma Patent Feud
A Delaware federal judge has affirmed a $34 million verdict against Alcon and related entities for infringing patents covering medical devices to treat glaucoma, disagreeing that Sight Sciences Inc. had failed to show the accused product meets the limitations of the patent claims.
-
March 30, 2026
Chancellor Rejects Musk Recusal Bid But Transfers Tesla Suits
The top judge of the Delaware Chancery Court on Monday rejected Elon Musk's bid to force her off three high-profile cases involving stockholders and Tesla, but reassigned the litigation anyway, citing concerns that intense public attention could undermine confidence in the proceedings.
-
March 27, 2026
Real Estate Recap: Private Credit, Multifamily Potential, ICE
Catch up on this past week's key developments by state from Law360 Real Estate Authority — including attorney insights into a pivotal moment for private credit, industry perspective on undervalued multifamily markets and a look at the litigation over immigration detention center projects.
-
March 27, 2026
Delaware Judge Lets Juul Suits Proceed, Trims Claims
Delaware Superior Court has largely allowed a set of lawsuits against Juul Labs Inc. to move forward, rejecting the company's bid to dismiss claims brought by more than a thousand plaintiffs who say they were misled about the risks of its e-cigarettes.
-
March 27, 2026
Nutrition Co. Execs Hid Stockpiling, Competition, Suit Says
The top brass of protein-shake maker BellRing Brands Inc. face a shareholder derivative suit in Delaware federal court, alleging they misled investors about the sales growth of "convenient nutrition" products like energy bars and protein powders, causing the company's stock price to fall when the truth was revealed.
-
March 27, 2026
Del. Justices Won't Revive Hedge Fund Insider Trading Case
The Delaware Supreme Court upheld a ruling Friday in favor of hedge fund Armistice Capital, backing the dismissal of a lawsuit accusing the firm of insider trading on information it had obtained in its position as a minority stakeholder of a pharmaceutical company.
-
March 27, 2026
ITC Will Review Solar Cell Imports For Infringement
The U.S. International Trade Commission is launching an investigation into claims by an Arizona-based solar company accusing nearly 50 companies of importing solar cells into the U.S. that infringe one of its patents.
Editor's Picks
-
DocuSign's Bad Conduct Warrants Fee Shift, Ex-CEO Says
DocuSign's ex-CEO wants the Delaware Chancery Court to order the e-signature company to pay at least $709,000 for legal fees he has incurred in litigation alleging the company tried to "bully" him into resigning from its board and made false filings saying he resigned as a director.
Expert Analysis
-
Berk May Spur More Pushback Against Med Mal Gatekeeping
The U.S. Supreme Court’s recent decision in Berk v. Choy may appear to be a run-of-the-mill reminder that a federal procedural rule trumps its state counterpart, but it could inspire more challenges to state-created prerequisites to filing medical malpractice lawsuits, say attorneys at Decof Mega.
-
Getting The Most Out Of Learning And Development Programs
Excerpt from Practical Guidance
Junior associates can better develop the legal, business and interpersonal skills they need for long-term success by approaching their firms’ learning and development programs armed with five tips for getting the most out of these resources, says Lauren Hakala at Reed Smith.
-
Del. Blackbaud Ruling Signals A New Era For Cyberinsurance
The recent Delaware Supreme Court ruling in Travelers v. Blackbaud shows that cyberinsurance is moving into a second maturity phase, in which insurers will increasingly attempt to recover their payments from vendors and insureds will face new pressure to justify cyber incident reimbursements, say Steven Teppler at Mandelbaum Barrett and Jade Davis at Shumaker.
-
Opinion
AI Presents A Make-Or-Break Moment For Outside Counsel
The rapid adoption of artificial intelligence by corporate legal departments is forcing a long-overdue reset of the relationship between inside and outside counsel, and introducing a significant opportunity to shed frustrating inefficiencies and strengthen collaboration for firms willing to embrace the shift, says Intel Chief Legal Officer April Miller Boise.
-
State Carbon Cost Disparities Are Pivotal In Data Center Siting
When choosing U.S. data center locations, developers must carefully consider the patchwork of state and regional carbon emission pricing regimes that are layered on top of the federal permitting framework, creating compliance cost differentials that could add up to billions of dollars, say attorneys at Davis Graham.
-
Series
Watching Hallmark Movies Makes Me A Better Lawyer
I realize you may be judging me for watching, and actually enjoying, Hallmark Channel movies, but the escapism and storylines actually demonstrate qualities and actions that lead to an efficient, productive and positive legal practice, says Karen Ross at Tucker Ellis.
-
Keys To Federal Carbon Compliance In Data Center Siting
Recent statements from the White House and state governors about making data centers pay for their own power infrastructure have underlined the importance of choosing locations, generation technologies and deal structures to optimize carbon, permitting and compliance costs, say attorneys at Davis Graham.
-
Moderna Case Highlights Overlooked Hurdle In Biopharma IP
The recent settlement of the patent litigation involving Moderna's COVID-19 vaccine in Delaware federal court shows that patent portfolios covering enabling platform technologies can create significant freedom-to-operate risk even when their owners are not direct competitors developing the therapeutic product, says Olga Berson at Thompson Coburn.
-
Emissions Permits May Not Override Pollution Exclusions
Two recent coverage rulings from the Illinois Supreme Court and the Third Circuit suggest a trend among appellate courts to deny coverage under pollution exclusions, even when the emissions happened pursuant to a government permit, say attorneys at Simpson Thacher.
-
5 Tips For Navigating Your Firm's All-Attorney Summit
Excerpt from Practical Guidance
Law firm retreats should be approached strategically, as they present valuable opportunities to advance both the firm's objectives and attorneys' professional development through meaningful participation, building and strengthening internal relationships, and proactive follow-up, says James Argionis at Cozen O’Connor.
-
Meta Coverage Ruling Could Erode Broad Duty To Defend
A Delaware court recently decided that Meta's insurers need not defend the company from lawsuits alleging addictive platform design — a troubling decision for policyholders that, if upheld, warns that insureds' business decisions can be weaponized to deny a duty to defend, say attorneys at Anderson Kill.
-
Series
Coaching Soccer Makes Me A Better Lawyer
Coaching youth soccer for my 7-year-old son's team has sharpened how I communicate with clients, prepare witnesses, work within teams and think about leadership, making me a more thoughtful and effective lawyer in many ways, says Joshua Holt at Smith Currie.
-
Series
Law School's Missed Lessons: The Human Element
Law school teaches you to quickly apply intellect and logic when handling a legal issue, but every fact pattern also involves a person, making the ability to balance expertise with empathy critical to the growth of relationships with clients, colleagues and adversaries, says Rachel Adcox at Adcox Strategies.
-
Avoid The Unexpected When Drafting License Agreements
The Delaware Court of Chancery's recent decision in Commave v. Zevrain raises several practice points for attorneys drafting commercial contracts, underscoring the importance of considering anti-assignment provisions, specific exclusions and potential carveouts when drafting license agreements or other commercial contracts, say attorneys at Hogan Lovells.
-
How DExit, Mandatory Arbitration Could Alter IPO Outlook
As companies continue to leave Delaware and the U.S. Securities and Exchange Commission begins allowing companies to implement mandatory arbitration provisions, these developments could have a major impact on the initial public offering, securities class action, and directors and officers insurance landscapes, says Walker Newell at Arthur J. Gallagher & Co.